En este importante evento el LAM561 es el único fármaco que está actualmente en un estadio de investigación tan avanzado como es el final de la fase clínica 3 y que se dirige a primera línea de ...
Read moreCRB Bio II, a life sciences–focused fund managed by CRB Health Tech (formerly CRB Inverbio), has completed its divestment from Health in Code (HiC), closing a full value creation cycle that began wi...
Read moreThe study will validate the safety of a novel topical ocular administration route for sitagliptin.
Read moreABE Capital and Columbus Venture Partners have reached an agreement to acquire a majority stake in Sermes CRO, a Spanish contract research organization specializing in end-to-end management of clinica...
Read moreAuthored by an international team with the significant involvement of researchers from IDIBAPS-Hospital Clínic Barcelona, JAMA Psychiatry has published the first review to synthesise and comprehensiv...
Read moreLa incubadora de alta tecnología alcanza el 85 % de ocupación en sus primeros siete meses de vida y se posiciona como un referente en la retención de talento científico.
Read moreAptadel Therapeutics takes another step forward in the development of its treatment for Ewing’s sarcoma. The biotechnology company has closed a bridge round of 2 million euros with the entry o...
Read moreBiotechnology company 53Biologics, specialized in the development and manufacturing of biologic drugs, has announced the closing of a strategic funding round led by European private equity firm Ren Li...
Read moreInceptionBio will focus on identifying, developing and building new companies around high-quality science, with a particular focus on Spain. The fund will primarily invest in technology transfer oppor...
Read moreLa startup, fundada por Alejandro Desco, busca ofrecer soluciones de almacenamiento energético fotovoltaico sostenibles y duraderas, desarrolladas y fabricadas localmente con un enfoque integral que ...
Read moreProceeds to support the advancement of three first- and best-in-class ADC programs through upcoming clinical milestones
Read moreThe Ministry of Science, Innovation and Universities (MICIU) has joined the CRB Digital Health III fund as an institutional investor, committing €10 million through the CDTI Innvierte programme.
Read more